News

Video

Further Testing Rivipansel and Its Implications Through the RESET Clinical Trial

Helen Thackray, MD, dives deeper into how the researchers tested rivipansel on the study participants and the implications compared to previous trials.

Pharmacy Times interviewed Helen Thackray, MD, on her presentation at the 62nd ASH Annual Meeting and Exposition. The presentation discusses research into rivipansel for acute vaso-occlusive crisis in sickle cell disease and the RESET clinical trial. In this video, Thackray dives deeper into how the researchers tested rivipansel on the study participants and the implications compared to previous trials.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Monoclonal antibodies are used to treat lung cancer. They are created in a lab and designed to target specific proteins on cancer cells, stopping them from growing and dividing.
Gene therapy in lung cancer (LC) - isometric view 3d illustration
© 2025 MJH Life Sciences

All rights reserved.